Difference between revisions of "Turner JH, et al. Cancer Biother. Radiopharm. (2003) cited as Ref 550 in DOI: 10.1038/s41392-020-0110-5 (Q9813)"

From Wikibase.slis.ua.edu
Jump to navigation Jump to search
(‎Created claim: Volume (P103): 18, #quickstatements; #temporary_batch_1590009084631)
(‎Created claim: Fifth Author string (P153): Leahy MF, #quickstatements; #temporary_batch_1590155508986)
 
(3 intermediate revisions by the same user not shown)
Property / title
 +
131I-anti CD20 radioimmunotherapy of relapsed or refractory non-Hodgkins lymphoma: a phase II clinical trial of a nonmyeloablative dose regimen of chimeric rituximab radiolabeled in a hospital (English)
Property / title: 131I-anti CD20 radioimmunotherapy of relapsed or refractory non-Hodgkins lymphoma: a phase II clinical trial of a nonmyeloablative dose regimen of chimeric rituximab radiolabeled in a hospital (English) / rank
 +
Normal rank
Property / Page(s)
 +
513-524
Property / Page(s): 513-524 / rank
 +
Normal rank
Property / Fourth Author string
 +
Claringbold PG
Property / Fourth Author string: Claringbold PG / rank
 +
Normal rank
Property / Fifth Author string
 +
Leahy MF
Property / Fifth Author string: Leahy MF / rank
 +
Normal rank

Latest revision as of 13:52, 22 May 2020

Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8
Language Label Description Also known as
English
Turner JH, et al. Cancer Biother. Radiopharm. (2003) cited as Ref 550 in DOI: 10.1038/s41392-020-0110-5
Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8

    Statements

    First Author string
    Turner JH
    0 references
    Second Author string
    Martindale AA
    0 references
    Third Author string
    Boucek J
    0 references
    PubMed ID
    14503945
    0 references
    Publication Date
    2003
    0 references
    Published In Name String
    Cancer Biother. Radiopharm.
    0 references
    Volume
    18
    0 references
    title
    131I-anti CD20 radioimmunotherapy of relapsed or refractory non-Hodgkins lymphoma: a phase II clinical trial of a nonmyeloablative dose regimen of chimeric rituximab radiolabeled in a hospital (English)
    0 references
    Page(s)
    513-524
    0 references
    Fourth Author string
    Claringbold PG
    0 references
    Fifth Author string
    Leahy MF
    0 references
     

    Sitelinks

    Retrieved from "http://wikibase.slis.ua.edu/w/index.php?title=Item:Q9813&oldid=207724"